Point72 Asset Management
BLUE

Point72 Asset Management’s bluebird bio BLUE Stock Holding History

Point72 Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,467
Closed -$1.02M – 911
2020
Q3 		$1.02M Buy
+1,467
New +$1.14M 0.01% 777

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Point72 Asset Management's BLUE Position: Q1 2024 in Review

Point72 Asset Management sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 29,220 shares — an estimated $806K sold.

Point72 Asset Management first reported a position in BLUE in Q2 2014 and held it in 17 quarters. The position peaked at $34.9M in Q2 2015. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • Point72 Asset Management reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
  • Point72 Asset Management sold 29,220 bluebird bio shares in Q1 2024, an estimated $806K.
  • Point72 Asset Management first reported a position in bluebird bio in Q2 2014 and held it in 17 quarters.
  • Point72 Asset Management's bluebird bio position peaked at $34.9M in Q2 2015.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on Point72 Asset Management's 13F filing for Q1 2024, filed 15 May 2024.